Spago Nanomedical Management
Management criteria checks 2/4
Spago Nanomedical's CEO is Mats Hansen, appointed in Jan 2015, has a tenure of 9.17 years. total yearly compensation is SEK2.08M, comprised of 78.7% salary and 21.3% bonuses, including company stock and options. directly owns 0.071% of the company’s shares, worth €3.92K. The average tenure of the management team and the board of directors is 5.2 years and 0.8 years respectively.
Key information
Mats Hansen
Chief executive officer
kr2.1m
Total compensation
CEO salary percentage | 78.7% |
CEO tenure | 9.2yrs |
CEO ownership | 0.07% |
Management average tenure | 5.2yrs |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -kr42m |
Sep 30 2023 | n/a | n/a | -kr41m |
Jun 30 2023 | n/a | n/a | -kr42m |
Mar 31 2023 | n/a | n/a | -kr44m |
Dec 31 2022 | kr2m | kr2m | -kr39m |
Sep 30 2022 | n/a | n/a | -kr39m |
Jun 30 2022 | n/a | n/a | -kr41m |
Mar 31 2022 | n/a | n/a | -kr43m |
Dec 31 2021 | kr2m | kr1m | -kr39m |
Sep 30 2021 | n/a | n/a | -kr32m |
Jun 30 2021 | n/a | n/a | -kr27m |
Mar 31 2021 | n/a | n/a | -kr20m |
Dec 31 2020 | kr2m | kr1m | -kr19m |
Sep 30 2020 | n/a | n/a | -kr20m |
Jun 30 2020 | n/a | n/a | -kr21m |
Mar 31 2020 | n/a | n/a | -kr21m |
Dec 31 2019 | kr2m | kr1m | -kr20m |
Sep 30 2019 | n/a | n/a | -kr18m |
Jun 30 2019 | n/a | n/a | -kr15m |
Mar 31 2019 | n/a | n/a | -kr13m |
Dec 31 2018 | kr1m | kr1m | -kr11m |
Compensation vs Market: Mats's total compensation ($USD196.43K) is below average for companies of similar size in the German market ($USD390.92K).
Compensation vs Earnings: Mats's compensation has increased whilst the company is unprofitable.
CEO
Mats Hansen (52 yo)
9.2yrs
Tenure
kr2,081,000
Compensation
Dr. Mats Hansen, MSc., PhD, serves as the Chief Executive Officer of Spago Nanomedical AB (publ) since 2015. Dr. Hansen has experience from different companies in the life science industry. He served at A...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 9.2yrs | kr2.08m | 0.071% SEK 3.9k | |
Chief Financial Officer | 5.2yrs | no data | 0.013% SEK 686.5 | |
Head of Research & Chief Scientific Officer | no data | no data | 0.031% SEK 1.7k | |
Chief Development Officer | 2.5yrs | no data | 0.011% SEK 610.3 |
5.2yrs
Average Tenure
53yo
Average Age
Experienced Management: 7UX's management team is seasoned and experienced (5.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Chairman of the Board | less than a year | no data | no data | |
Medical Advisor | less than a year | kr95.00k | 0.0081% SEK 446.9 | |
Independent Director | less than a year | no data | no data | |
Medical Advisor | less than a year | kr95.00k | no data | |
Independent Director | 6.2yrs | kr95.00k | 0.037% SEK 2.0k | |
Medical Advisor | 1.8yrs | no data | no data | |
Independent Director | 4.6yrs | kr95.00k | 0.0037% SEK 201.8 | |
Medical Advisor | 1.8yrs | no data | no data | |
Medical Advisor | less than a year | no data | no data | |
Medical Advisor | less than a year | no data | no data |
0.8yrs
Average Tenure
64yo
Average Age
Experienced Board: 7UX's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.